The U.S. health care reform opportunity: a fresh look at government as a key stakeholder.

This report provides a summary of the U.S. health care reform issues that have emerged as important to various industries, including Life Sciences. For Life Sciences companies in particular, the implications of those issues are examined and a new approach in addressing the government as a key stakeholder is explored.